OPK · OPKO Health, Inc.

Notes & Operating Detail

Balance Sheet & Liquidity

No balance sheet data available in the Notes section provided.

Commitments & Contractual Obligations

No commitments or obligations disclosed in the extracted Notes content.

Capital Allocation

No capital allocation activities (buybacks, dividends, debt changes, capex) reported in the Notes.

Segment / Geographic Mix

No segment-level financial data was found in the Notes section.

Cash Flow Quality

Cash Flow Quality — CFO vs Net Income, capex intensity, FCF coverage of capital returns.

OPKO Health reported positive operating cash flow of $4.5 million for the three months ended March 31, 2026, a significant improvement from a negative $5.2 million in the same period of 2025. This turnaround reflects better working capital management and potentially improved operational efficiency. The company's net income was not provided in the cash flow excerpt, but the positive CFO indicates cash generation from core operations. Capital expenditures were minimal at $0.1 million, resulting in a free cash flow of approximately $4.4 million (operating cash flow less capex). No share repurchases or dividends were recorded during the quarter, so the entire free cash flow was retained on the balance sheet.

Anomalies & Observations

• Investing cash flow was negative $1.2 million, mostly attributable to capex and possibly other investing activities.
• Financing cash flow was negative $0.3 million, which may relate to debt repayments or other financing transactions.
• The year-over-year comparison is striking: CFO swung from negative to positive, representing a 186.5% improvement, indicating a strong operational recovery.
• No significant one-time tax payments or large working capital swings were explicitly disclosed, but the improvement suggests tighter receivables and payables management.